Navigation Links
Mesa Labs Acquires the Biological Indicators Business of Apex Laboratories, Inc.
Date:12/21/2010

LAKEWOOD, Colo., Dec. 21, 2010 /PRNewswire-FirstCall/ -- Mesa Laboratories, Inc. (Nasdaq: MLAB), a Lakewood, Colorado based manufacturer of electronic instruments and disposables today announced the acquisition of the biological indicators business of Apex Laboratories, Inc., a North Carolina based company.  The acquisition of the Apex business is expected to be immediately accretive to Mesa's earnings per share.

Apex Labs is the worldwide leader in sales of biological indicators (BI) for hydrogen peroxide vapor systems that operate at ambient pressures.  These processes are commonly used for decontamination of glove boxes, aseptic processing lines, and  entire rooms in the pharmaceutical, medical device, healthcare, and food industries.  Biological indicators are used to ensure that the conditions in enclosures are appropriate to achieve the proper level of decontamination.  Apex pioneered this market in the mid-1990's with the introduction of a BI using a small stainless steel disk as the bacterial spore carrier.  As the market grew, the Apex disk became the standard in the industry for quality control applications.  

Mesa Labs was founded in 1982 and manufactures instruments and disposable products utilized in connection with industrial applications and healthcare.  Products include DataTrace data loggers and Torqo torque testers for quality control applications in pharmaceutical, food, and medical device manufacturing; Medical meters used for quality control in dialysis clinics; and Biological Indicators used for quality control of sterilization processes in hospitals and dental offices, along with pharmaceutical and medical device companies.

In this transaction, Apex is selling to Mesa Labs the assets associated with their hydrogen peroxide BI products and services.  Following a brief transition period, Mesa will be relocating the Apex business to its newly acquired SGM Biotech division in Bozeman, Montana.

"We are delighted to announce the addition of the Apex line of biological indicators to Mesa's BI businesses," said John J. Sullivan, President and CEO of Mesa Labs.  "The Apex hydrogen peroxide BI products complement Mesa Labs' existing line of biological indicators.  Apex has captured the major share of this market, due to the excellent customer service and performance characteristics of their hydrogen peroxide BI.  Now, with the addition of the Apex BI, Mesa will be able to capitalize on the opportunities in this rapidly growing market."

"I am pleased to find a quality organization like Mesa to continue the Apex BI product line," said Joseph P. Dalmasso, President of Apex.  "I respect the technical expertise and excellent customer support that resides in Mesa's organization, and I am confident the many loyal customers Apex developed over the past thirteen years will be well served by Mesa's staff."

This news release contains forward-looking statements which involve risks and uncertainties.  The Company's actual results could differ materially from those in any such forward-looking statements.  Additional information concerning important factors that could cause results to differ materially from those in any such forward-looking statement is contained in the Company's Annual Report on Form-10K for the year ended March 31, 2010 as filed with the Securities and Exchange Commission, and from time to time in the Company's other reports on file with the Commission.

www.mesalabs.com


'/>"/>
SOURCE Mesa Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Adeona Acquires Access to Clinical Data Supporting Oral Zinc for Prevention of Infections in the Elderly
2. Medicalis Acquires RadWorkFlow from Inland Imaging and Providence Health Care
3. Cambrex Acquires Stake in Zenara Pharma
4. RoundTable Healthcare Partners Acquires Majority Stake in Salter Labs
5. Essential Pharmaceuticals Acquires Exclusive Worldwide Rights to Family of Cell Media Products from Lifeblood Medical
6. WomanCare Global Acquires 2 Global Brands From ICON -- Combined Oral Contraceptive Roselle® and Emergency Contraceptive Optinor®
7. MEI Development Acquires Oncology Group; Names Founder as Head of Oncology Division
8. Nexcore Acquires Meditron Line of Medical Products
9. Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
10. MultiCells Majority Owned Subsidiary Acquires Bioabsorbable Interventional Cardiology Stent Assets
11. Roche Acquires RALS IT Connectivity Assets to Strengthen Presence in Point-of-Care Information Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... South Africa , Feb. 20, 2017  There ... illness and non-communicable diseases (NCDs) across sub-Saharan Africa, which ... drugs. The growing incidence of more Western lifestyle diseases ... disease, in addition to infectious and parasitic illness, will ... with a business opportunity of $40.8 billion in ...
(Date:2/20/2017)... According to a new market research report "Pulmonary/ Respiratory Drug ... dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End User (Hospitals, Homecare), Applications ... to reach USD 52.37 Billion by 2021 from USD 36.10 Billion in ... Continue Reading ... ...
(Date:2/20/2017)... --  Alberty   Drugs , a leading ... has announced a significant shift in focus by concentrating ... servicing local Veteran Affairs Centers (VA) and other Federal ... need to secure cost effective treatments for their patients, ... their goods & services. "The opportunity to ...
Breaking Medicine Technology:
(Date:2/19/2017)... ... 2017 , ... ProBrand Glitch is a set of 30 glitch distortion logo reveals made exclusively ... any logo with a glitch reveal in just a few clicks of a mouse. Customizable ... of each preset. Use these presets to add a uniquely animated logo to any photos ...
(Date:2/18/2017)... VA (PRWEB) , ... February ... ... of Change for Devicemakers , Sponsored by Axendia, **FDAnews Free Webinar**, March ... , Are manufacturers looking to reduce their regulatory burden? Pay dividends in ...
(Date:2/18/2017)... ... 17, 2017 , ... CONTACT:, Glenn Vallecillos, MD, FACS, +1 ... Dr. Glenn Vallecillos experiments SculpSure, the hot, new, aesthetic, non-surgical procedure ... been centered around that idea that to achieve ones desired results a surgical ...
(Date:2/18/2017)... , ... February 18, 2017 , ... ... provides the latest information and contact points to easily connect elderly veterans of ... assisted living, and elder-care funding. It also conveys material on this year's increase ...
(Date:2/17/2017)... San Diego, CA (PRWEB) , ... February 17, ... ... new initiative—InvestUp—to focus on foundational and sustainable systems change designed to further positively ... Counties. , “The Board of Trustees has long considered it our duty to ...
Breaking Medicine News(10 mins):